title: Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients.
abstract: OBJECTIVE
  Extensive loss of adipose tissue is a key feature of cancer cachexia. Advanced cancer patients also exhibit low plasma phospholipids. It is not known whether these processes coincide across the cancer trajectory nor has their relationship with survival been defined. Changes in adipose tissue mass and plasma phospholipids were characterized within 500days prior to death and prognostic significance assessed.
  
  
  METHODS
  Adipose tissue rate of change was determined in a retrospective cohort of patients who died of colorectal and lung cancers (n=108) and who underwent >2 computed tomography scans in the last 500days of life. Plasma phospholipid fatty acids were measured prospectively in a similar cohort of patients with metastatic cancer (n=72).
  
  
  RESULTS
  Accelerated loss of adipose tissue begins at 7months from death reaching an average loss of 29% of total AT 2months from death. Plasma phospholipid fatty acids were 35% lower in patients closest to death versus those surviving >8months. Losses of phospholipid fatty acids and adipose tissue occur in tandem and are predictive of survival.
  
  
  CONCLUSIONS
  Depletion of plasma phospholipids likely indicates a deficit of essential fatty acids in the periphery which may contribute to loss of adipose tissue.
authors: Alberta Institute for Human Nutrition, University of Alberta, 4-10 Agriculture/Forestry Centre Edmonton, Alberta, T6G 2P5, Canada.
authors: R A
authors: RA
authors: Murphy
authors: M S
authors: MS
authors: Wilke
authors: M
authors: M
authors: Perrine
authors: M
authors: M
authors: Pawlowicz
authors: M
authors: M
authors: Mourtzakis
authors: J R
authors: JR
authors: Lieffers
authors: M
authors: M
authors: Maneshgar
authors: E
authors: E
authors: Bruera
authors: M T
authors: MT
authors: Clandinin
authors: V E
authors: VE
authors: Baracos
authors: V C
authors: VC
authors: Mazurak
mesh_terms: D052436:Adipose Tissue, White / Q000378:metabolism*; D050154:Adiposity; D000368:Aged; D002100:Cachexia / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology / Q000378:metabolism*; D015331:Cohort Studies; D018450:Disease Progression; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006801:Humans; D050152:Intra-Abdominal Fat / Q000378:metabolism; D008066:Lipolysis; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000378:metabolism; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D010743:Phospholipids / Q000097:blood* / Q000378:metabolism; D011379:Prognosis; D012189:Retrospective Studies; D050151:Subcutaneous Fat / Q000378:metabolism; D016019:Survival Analysis
chemical_list: D005227:Fatty Acids; D010743:Phospholipids